Bakhu Holdings (BKUH) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 0 4 sessions, June 10, 2025 to March 27, 2026
Company Description
Bakhu Holdings (OTC: BKUH) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector.
For FY2024, Bakhu Holdings reported revenue of $0.
This page collects what Stock Titan holds for BKUH, including price data, latest news, SEC filings, and financial highlights.
Stock Performance
Bakhu Holdings (BKUH) closed at $0.0005 on March 27, 2026.
BKUH Metrics & Rankings
Price returns through March 27, 2026. Ranking links may use different dates.
Latest News
Bakhu Holdings has 5 recent news articles. Key topics include management. View all BKUH news →
SEC Filings
Bakhu Holdings has filed 5 recent SEC filings, including 3 Form 10-Q, 1 Form 10-K, 1 Form 8-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BKUH SEC filings →
Financial Highlights
Upcoming Events
BKUH Company Profile & Sector Positioning
Bakhu Holdings (BKUH) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing BKUH often look at related companies in the same sector, including Merck KGaA (MKGAF), Merck KGaA (MKKGY), Takeda Pharm Co Ltd (TKPHF), Galderma Group AG (GALDY), and Galderma Group AG (GDERF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BKUH's relative position within its industry.